Trial · NCT07889466
Registered outcomes17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from Baseline and Placebo in Total Sleep Time | 6 weeks, nightly in baseline, placebo, and intervention. | Smartwatch-derived objective total sleep time in minutes. |
| Primary | Change from Baseline and Placebo in the Count of Lapse in Psychomotor Vigilance Task (PVT) | 6 weeks, daily in baseline, placebo, and intervention. | Count of responses with reaction time greater than 500 milliseconds in a PVT session. |
| Primary | Change from Baseline and Placebo in Subjective Sleep Quality | 6 weeks, daily in baseline, placebo, and intervention. | Self-reported sleep quality score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
| Secondary | Change from Baseline and Placebo in Sleep Efficiency | 6 weeks, nightly in baseline, placebo, and intervention. | Objective total sleep time divided by time in bed, in percentage points. |
| Secondary | Change from Baseline and Placebo in Sleep Fragmentation Index | 6 weeks, nightly in baseline, placebo, and intervention. | Waking bouts per 100 min of objective total sleep time. |
| Secondary | Change from Baseline and Placebo in Wake After Sleep Onset | 6 weeks, nightly in baseline, placebo, and intervention. | Objective total time awake after sleep onset and before wake onset, in minutes. |
| Secondary | Change from Baseline and Placebo in Deep Sleep Duration | 6 weeks, nightly in baseline, placebo, and intervention. | Smartwatch-derived deep sleep duration in minutes. |
| Secondary | Change from Baseline and Placebo in Deep Sleep Percentage | 6 weeks, nightly in baseline, placebo, and intervention. | Smartwatch-derived deep sleep in percentage of objective total sleep time. |
| Secondary | Change from Baseline and Placebo in Rapid Eye Movement (REM) Sleep Duration | 6 weeks, nightly in baseline, placebo, and intervention. | Smartwatch-derived REM sleep duration in minutes. |
| Secondary | Change from Baseline and Placebo in Rapid Eye Movement (REM) Sleep Percentage | 6 weeks, nightly in baseline, placebo, and intervention. | Smartwatch-derived REM sleep in percentage of objective total sleep time. |
| Secondary | Change from Baseline and Placebo in Mean Response Speed | 6 weeks, daily in baseline, placebo, and intervention. | Mean reciprocal reaction time in a PVT session, in per second. |
| Secondary | Change from Baseline and Placebo in Mean Slowest-10% Response Speed | 6 week, daily in baseline, placebo, and intervention. | Mean reciprocal reaction time over the slowest 10% responses in a PVT session, in per second. |
| Secondary | Change from Baseline and Placebo in Subjective Alertness | 6 weeks, daily in baseline, placebo, and intervention. | Daily self-reported alertness score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
| Secondary | Change from Baseline and Placebo in Subjective Happiness | 6 weeks, daily in baseline, placebo, and intervention. | Self-reported happiness score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
| Secondary | Change from Baseline and Placebo in Subjective Energy | 6 weeks, daily in baseline, placebo, and intervention. | Self-reported energy score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
| Secondary | Change from Baseline and Placebo in Subjective Health | 6 weeks, daily in baseline, placebo, and intervention. | Self-reported health score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
| Secondary | Change from Baseline and Placebo in Subjective Calmness | 6 weeks, daily in baseline, placebo, and intervention. | Self-reported calmness score on a visual analogue scale of 0 to 100, higher indicating more favorable. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07889466/registered